Coronary stent in Idaho: the highest-volume physicians
23 physicians in Idaho billed Medicare for 708 coronary stent procedures in 2024. The top 23, with the year before beside it.
Top 23
| Rank | Physician | 2024 | 2023 | Change |
|---|---|---|---|---|
| 1 | John D. Chambers, MDCardiology · Idaho Falls | 89 | 68 | +31% |
| 2 | Edward Kim, MDCardiology · Lewiston | 61 | 67 | −9% |
| 3 | Robert W. Tonks, MDInterventional Cardiology · Twin Falls | 54 | 67 | −19% |
| 4 | Aditya SinghCardiology · Pocatello | 40 | 17 | |
| 5 | Charles Q. Cui, MDCardiology · Coeur D Alene | 38 | 51 | −25% |
| 5 | Joseph C. Hymas, MDInterventional Cardiology · Twin Falls | 38 | 23 | +65% |
| 7 | Donald F. Engles, MDInterventional Cardiology · Coeur D Alene | 33 | 25 | +32% |
| 8 | Joseph A. Walsh, MDInterventional Cardiology · Boise | 32 | 28 | +14% |
| 9 | Elizabeth M. Rau, MDInterventional Cardiology · Coeur D Alene | 31 | 36 | −14% |
| 10 | Kara Denby, MDCardiology · Boise | 29 | 12 | |
| 10 | Eric L. Wallace, DOInterventional Cardiology · Coeur D Alene | 29 | 30 | −3% |
| 12 | Mark G. Parent, MDInterventional Cardiology · Boise | 28 | 42 | −33% |
| 13 | Dennis M. Enomoto, MDCardiology · Twin Falls | 27 | 29 | −7% |
| 14 | Troy J. Badger, MDCardiology · Boise | 26 | — | |
| 15 | Frederick M. Costello, MDInterventional Cardiology · Boise | 22 | 16 | |
| 16 | Alex C. Johnson, MDInterventional Cardiology · Boise | 19 | 24 | −21% |
| 16 | Fernando Grigera, MDInterventional Cardiology · Pocatello | 19 | 35 | −46% |
| 16 | Ronald D. Jenkins, MDInterventional Cardiology · Sandpoint | 19 | 18 | |
| 19 | Mark A. TroianoCardiology · Coeur D Alene | 18 | 14 | |
| 20 | Trey L. Oxford, MDInterventional Cardiology · Nampa | 16 | 30 | −47% |
| 21 | Robert L. Duerr, MDInterventional Cardiology · Boise | 14 | 19 | |
| 21 | Rosie Jasper, DOCardiology · Nampa | 14 | 18 | |
| 23 | Kendra Coonse, MDCardiology · Boise | 12 | 12 |
A rank counts procedures billed under the physician's own NPI (CPT 92928), in 2024, Medicare fee-for-service only. A surgeon who mostly treats younger or Medicare Advantage patients will rank lower than their total volume. Method and limits.